Episode 95

Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 3

Featuring perspectives from Prof John Seymour, including the following topics:

  • Safety of fixed-duration acalabrutinib/venetoclax for chronic lymphocytic leukemia (CLL) (0:00)
  • Venetoclax re-treatment and ongoing trials with acalabrutinib/venetoclax for CLL (6:21)
  • First-line treatment with sonrotoclax and zanubrutinib for CLL (13:10)

CME information and select publications

Next Episode All Episodes Previous Episode

About the Podcast

Show artwork for Hematologic Oncology Update
Hematologic Oncology Update
This series bridges the gap between research and patient care by providing medical oncologists with access to important information on relevant advances in the treatment of hematologic malignancies.

Listen for free